Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NKGN
NKGEN BIOTECH, INC.
OTC
$0.00
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$274.26 K
52w High$0.77
52w Low$0.00
Dividend Yield—
Frequency—
P/E-0.01
Volume3.77K
Shares Out.130.60M

COMPANY

LEADERSHIP

Paul Y. Song
CHIEF EXECUTIVE
Paul Y. Song

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 13, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
26

PRICE

$0.00 ▲ UP 0.00% (+$0.00)
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.0010:01 AM10:09 AM10:17 AM10:25 AM10:34 AM10:42 AM10:50 AM0.00

About NKGen Biotech, Inc.

https://nkgenbiotech.com ↗

NKGen Biotech, a 2017-founded Santa Ana-based biotech, develops NK cell therapies for neurodegenerative and cancer diseases, with products in clinical trials and partnerships in Japan and Korea.

INDUSTRY

Biotechnology

A PRODUCT NKGEN BIOTECH, INC. IS KNOWN FOR

Troculeucel (SNK01)
Troculeucel (SNK01)

Troculeucel is an investigational autologous NK cell therapy by NKGen Biotech, targeting neurodegenerative diseases like Alzheimer's and cancers.

COMPETITORS

COMPETITOR
CELU COMPARE
FATE COMPARE
GTBP COMPARE
MRKR COMPARE
NKTX COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
2.12%
HOLDERS
2
TOP 2 OF 2 · RANKED BY POSITION SIZE
Meteora Capital, LLC
2.8M sh · $137.8K
Blackrock Inc.
17.0K sh · $21.55K

SECTORS PEERS

PEERPRICE
GYRE$6.59COMPARE
FBIOP$18.61COMPARE
COYA$4.59COMPARE
VRAX$2.89COMPARE
BRNS$0.75COMPARE
KTTA$0.56COMPARE
MLEC$6.77COMPARE
ELAB$0.90COMPARE